Navigation Links
NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update

HUBBARD, Ohio, May 28 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (Pink Sheets: NNLX) a nano-biotechnology company is pleased to provide the following updates:

NanoLogix personnel will showcase company technology at booth 1304 at the ASM General Meeting and Exhibition in Boston, June 1-5 2008. The ASM meeting is the world's premier event for microbiology development. Representing NanoLogix will be Dr. Sergey Gazenko and CEO Bret Barnhizer. Exhibition information can be found at

At the ASM meeting NanoLogix will unveil ten products for use with their BNC and BNP technology for fast microorganism detection. This step is a milestone in company development. Director and company founder Dr. Robert A. Ollar, M.Sc., Ph.D. stated: "The sale of products developed by NanoLogix scientific staff marks an important stage in the evolution of the company. The firm is now putting its technologies into actual product configurations, and offering them for sale in the international market place where they will be utilized by the Global Scientific Community."

The company is also planning a new research and development facility in northeast Ohio. This facility will enable expanded R&D work on both Biohydrogen reactor development and BioNanoChannel (BNC) and BioNanoPore (BNP) technologies.

Hilda E. Diaz has joined NanoLogix in Cincinnati as assistant to Dr. Sergey Gazenko. Ms. Diaz holds an MS in Microbiology from Xavier University in Colombia, a BS in Bacteriology from Catholic University, and a BA in Business Administration. Ms. Diaz has extensive research and work experience in the field of microbiology. She was Professor in general microbiology, food microbiology and biotechnology at Catholic University in Colombia, and has extensive industrial experience in bacteriological testing. The company is pleased to have Ms. Diaz contributing to its efforts to further both Biohydrogen and BioNanoChannel technologies.

About NanoLogix, Inc.

NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and multiple Patents Pending for bioreactor- based Hydrogen Production, revolutionary rapid medical testing technologies, and bioremediation. Information on NanoLogix is available at

This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact: Investor Relations

Bret Barnhizer, CEO

Telephone: 330-534-0800


SOURCE NanoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
2. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
3. National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welchs Foods
4. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
5. NanoLogix, Inc. Makes Stock Pick List
6. NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update
7. NanoLogix Inc. to Present at EBW Expo & Conference 2007
8. NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welchs
9. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
10. Abbott to Present at Goldman Sachs Global Healthcare Conference
11. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Post Your Comments:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
Breaking Biology Technology:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):